IgD monoclonal gammopathy of undetermined significance

International Journal of Hematology

Volumn 65, Issue 2, 1997, Pages 169-172

  Kinoshita, Tomohiro ^a   Nagai, Hirokazu ^a   Murate, Takashi ^a   Saito, Hidehiko ^a   Fukatsu, Toshiaki ^a   Hotta, Tomomitsu ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgD; M protein; MGUS; Multiple myeloma

Indexed keywords

IMMUNOGLOBULIN D;

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0031081686     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(96)00557-9     Document Type: Article

References (9)

1. [1] Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 1978;64:814-826.
2. [2] Kyle RA, Lust JA. Monoclonal gammopathy of undetermined significance. Semin Hematol 1989;26:176-200.
3. [3] Kyle RA, Greipp PR. 'Idiopathic' Bence Jones proteinuria. Long-term follow-up in seven patients. N Engl J Med 1982;306:564-567.
4. [4] Fibbe WE, Jansen J. Prognostic factors in IgD myeloma: a study of 21 cases. Scand J Haematol 1984;33:471-475.
5. [5] Shimamoto Y, Anami Y, Yamaguchi M. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur J Haematol 1991;47:262-267.
6. [6] Bladé J, Lust JA, Kyle RA. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases. J Clin Oncol 1994;12:2398-2404.
7. [7] O'Connor ML, Rice DT, Buss DH, Muss HB. Immunoglobulin D benign monoclonal gammopothy. Cancer 1991;68:611-616.
8. [8] Bladé J, Kyle RA. IgD monoclonal gammopathy with long-term follow-up. Br J Haematol 1994;88:395-396.
9. [9] Hansen PR, Jønssonn V, Schrøder HD, Jensen TS, Wiik A. IgD-λ monoclonal gammaopathy and axonal neuropathy. J Intern Med 1989;225:289-290.